CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
More than a quarter of children in US children's hospitals are receiving suboptimal antibiotic therapy, and antibiotic stewardships programs (ASPs) miss a substantial portion of it, according to a study yesterday in Clinical Infectious Diseases.
The death in China is the second in the outbreak.
The WHO says 14 cases reported in the past week have all been traced to the same area.
Firms say they can't sustain a viable pipeline of products to address antibiotic resistance on their own.
A team of Spanish scientists reports that after they implemented an antimicrobial stewardship program (ASP) focused on antifungal use at their university hospital in Seville, use of antifungal drugs dropped 38%, according to their findings published yesterday in the Journal of Infection.
Saudi Arabia's Ministry of Health (MOH) today reported one more MERS-CoV case recorded earlier this week, the fourth to be reported in January.
Only 360 providers (1.7%) were in the highest-prescribing group.
New details in the outbreak emerge, including potential human-to-human spread.
Also, Profectus's second-generation VSV vaccine shows promise in a phase 1 trial.
The Centers for Disease Control and Prevention (CDC) said today a multistate outbreak of Escherichia coli O157:H7 infections tied to contaminated romaine lettuce grown in Salinas, California, appears to be over.
Medical students posing as patients were able to obtain antibiotics without a prescription in 84% of Chinese retail pharmacies, Chinese researchers reported today in Antimicrobial Resistance and Infection Control.
Also, a health official says there may be a family cluster among the outbreak patients.
The study shows how tolerance promotes the evolution of resistance with combination antibiotics.
According to the World Health Organization's (WHO's) online Ebola dashboard, officials in the Democratic Republic of the Congo (DRC) tracked 5 new cases of Ebola today, raising the outbreak total to 3,403, including 2,235 fatalities. The death toll has not changed since last week.
A total of 410 suspected cases are still under investigation.
The woman has no fever or respiratory symptoms and may go home soon.
Possible reasons include low natural immunity and viral evolution.
CARB-X today said it has awarded Trellis Bioscience of Redwood City, California, up to $3.2 million to develop an innovative monoclonal antibody designed to disrupt the protective biofilm that makes bacteria resistant to antibiotics.
The World Health Organization's (WHO's) online Ebola dashboard reflects 5 new cases of the viral disease over the weekend, including 3 cases reported today. The outbreak total now stands at 3,398, including 2,235 fatalities.
Officials are still investigating 410 suspected cases.
Officials put the case count at 41 and note how the new virus relates to the SARS virus.
Wuhan's health commission hasn't released any updates on the outbreak since Jan 5.
